We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · March 30, 2017

Effect of Sacubitril/Valsartan vs Enalapril on Glycemic Control in Patients With Heart Failure and Diabetes

The Lancet Diabetes & Endocrinology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Diabetes & Endocrinology
Effect of Sacubitril/Valsartan Versus Enalapril on Glycaemic Control in Patients With Heart Failure and Diabetes: A Post-Hoc Analysis From the PARADIGM-HF Trial
Lancet Diabetes Endocrinol 2017 Mar 18;[EPub Ahead of Print], JP Seferovic, B Claggett, SB Seidelmann, EW Seely, M Packer, MR Zile, JL Rouleau, K Swedberg, M Lefkowitz, VC Shi, AS Desai, JJ McMurray, SD Solomon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading